Intestinal Type and Endocervical-like Ovarian Mucinous Neoplasms are Immunophenotypically Distinct Entities
Authors:
- Xiaoqi LinXLXiaoqi Lin
- Jennifer L. LindnerJLJennifer L. Lindner
- Jan F. SilvermanJSJan F. Silverman
- Yulin LiuYLYulin Liu
- 1 October 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 16 (5) , 453-458
Abstract
Ovarian mucinous neoplasm (OMN) is traditionally classified as either intestinal type or endocervical-like subtypes. The 2 subtypes represent different clinicopathologic characteristics. The immunophenotype of the 2 subtypes has not been adequately investigated. In this study, we investigated 14 intestinal type OMNs (borderline and adenocarcinoma) and 12 endocervical-like OMNs (borderline and adenocarcinoma) for their expression of PDX-1, CDX-2, CA-125, CK7, CK20, WT-1, D2-40, and TTF-1. We also included 15 colorectal adenocarcinomas metastatic in the ovary, as they may occasionally mimic OMN. The intestinal type OMNs were positive for PDX-1 (100%), CK7 (100%), CK20 (100%), CDX-2 (29%), whereas were negative for CA-125. The endocervical-like OMNs were positive for CA-125 (100%) and CK7 (100%), whereas were negative for CK20, PDX-1, and CDX-2. Metastatic colorectal adenocarcinomas were positive for CK20 (100%), CDX-2 (100%), and PDX-1 (33%), whereas were negative for CA-125 and CK7. All of the intestinal type and endocervical-like OMNs as well as metastatic colorectal adenocarcinomas were negative for WT-1, D2-40, and TTF-1. Our results demonstrated that the intestinal type and endocervical-like OMNs are immunophenotypically distinct entities. The 2 subtypes can be separated from metastatic colorectal adenocarcinoma by the different immunohistochemical profile of PDX-1, CA-125, CK7, CK20, and CDX-2. In the work-up of mucinous adenocarcinoma in the ovary or abdominal cavity, caution should be exercised in interpreting the possible primary site on the basis of the immunohistochemical profiles.Keywords
This publication has 27 references indexed in Scilit:
- Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinomaLaboratory Investigation, 2005
- The Usefulness of CDX-2 for Differentiating Primary and Metastatic Ovarian Carcinoma: An Immunohistochemical Study Using a Tissue MicroarrayJournal of Korean Medical Science, 2005
- The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomasLaboratory Investigation, 2004
- PDX-1 and the PancreasPancreas, 2004
- CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal OriginAmerican Journal of Surgical Pathology, 2003
- Expression of Cytokeratins 7 and 20 in Ovarian NeoplasiaAmerican Journal of Clinical Pathology, 2002
- Clear Cell Carcinoma of the Urinary BladderAmerican Journal of Surgical Pathology, 2002
- Mucinous Tumors of the OvaryAmerican Journal of Surgical Pathology, 2002
- Evaluation of Diagnostic Criteria and Behavior of Ovarian Intestinal-Type Mucinous TumorsAmerican Journal of Surgical Pathology, 1999
- Primary Ovarian Mucinous CystadenocarcinomasAmerican Journal of Surgical Pathology, 1998